SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
DURUS CAPITAL MANAGEMENT

(Last) (First) (Middle)
113 POST RD. EAST

(Street)
WESTPORT CT 06880

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ESPERION THERAPEUTICS INC/MI [ ESPR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
05/29/2002
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 06/25/2003 S 15,900(2) D $14.7512 11,063,588(2) I See Footnote(3)
Common Stock(1) 06/26/2003 P 468,000(2) A $18.0909 11,531,588(2) I See Footnote(3)
Common Stock(1) 06/26/2003 S 12,400(2) D $14.7693 11,519,188(2) I See Footnote(3)
Common Stock(1) 06/26/2003 S 20,000(2) D $17.6792 11,499,188(2) I See Footnote(3)
Common Stock(1) 06/26/2003 S 214,900(2) D $17.7712 11,284,288(2) I See Footnote(3)
Common Stock(1) 06/27/2003 P 18,600(2) A $18.8076 11,302,888(2) I See Footnote(3)
Common Stock(1) 06/27/2003 S 16,700(2) D $18.5841 11,286,188(2) I See Footnote(3)
Common Stock(1) 06/27/2003 S 155,600(2) D $18.5612 11,130,588(2) I See Footnote(3)
Common Stock(1) 06/30/2003 P 12,500(2) A $19.519 11,143,088(2) I See Footnote(3)
Common Stock(1) 06/30/2003 S 62,400(2) D $19.4549 11,080,688(2) I See Footnote(3)
Common Stock(1) 06/30/2003 S 19,500(2) D $18.8891 11,061,188(2) I See Footnote(3)
Common Stock(1) 06/30/2003 S 38,100(2) D $19.4381 11,023,088(2) I See Footnote(3)
Common Stock(1) 06/30/2003 S 50,000(2) D $19.4406 10,973,088(2) I See Footnote(3)
Common Stock(1) 07/01/2003 P 5,000(2) A $19.1732 10,978,088(2) I See Footnote(3)
Common Stock(1) 07/01/2003 S 130,000(2) D $19.239 10,848,088(2) I See Footnote(3)
Common Stock(1) 07/01/2003 S 20,000(2) D $19.5519 10,828,088(2) I See Footnote(3)
Common Stock(1) 07/01/2003 S 3,800(2) D $19.4146 10,824,288(2) I See Footnote(3)
Common Stock(1) 07/02/2003 P 39,300(2) A $19.0424 10,863,588(2) I See Footnote(3)
Common Stock(1) 07/02/2003 P 35,000(2) A $19.0258 10,898,588(2) I See Footnote(3)
Common Stock(1) 07/02/2003 S 55,000(2) D $19.0127 10,843,588(2) I See Footnote(3)
Common Stock(1) 07/02/2003 S 66,500(2) D $19.017 10,777,088(2) I See Footnote(3)
Common Stock(1) 07/02/2003 S 19,624(2) D $19.063 10,757,464(2) I See Footnote(3)
Common Stock(1) 07/02/2003 S 26,900(2) D $19.0366 10,730,564(2) I See Footnote(3)
Common Stock(1) 07/03/2003 P 13,600(2) A $19.1375 10,744,164(2) I See Footnote(3)
Common Stock(1) 07/03/2003 S 14,800(2) D $19.0891 10,729,364(2) I See Footnote(3)
Common Stock(1) 07/03/2003 S 7,000(2) D $19.1291 10,722,364(2) I See Footnote(3)
Common Stock(1) 07/03/2003 S 26,000(2) D $19.1196 10,696,364(2) I See Footnote(3)
Common Stock(1) 07/07/2003 P 2,700(2) A $19.5238 10,699,064(2) I See Footnote(3)
Common Stock(1) 07/07/2003 S 37,600(2) D $19.4704 10,661,464(2) I See Footnote(3)
Common Stock(1) 07/07/2003 S 40,000(2) D $19.4366 10,621,464(2) I See Footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
DURUS CAPITAL MANAGEMENT

(Last) (First) (Middle)
113 POST RD. EAST

(Street)
WESTPORT CT 06880

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
DURUS CAPITAL MANAGEMENT NA LLC

(Last) (First) (Middle)

(Street)

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
SACANE SCOTT

(Last) (First) (Middle)

(Street)

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. This Form 4 is being filed by Durus Capital Management, LLC ("Capital"), Durus Capital Management (N.A.), LLC ("Management") and Scott Sacane. Because the SEC's electronic filing system does not allow for the disclosure of more than 30 transactions on one Form 4, the Reporting Persons are filing 24 simultaneous Form 4s to report their reportable transactions all of which together shall be deemed a single report filed on this date. This is the 22nd Form 4 of the 24 filings.
2. In accordance with instruction 4(b)(iv) of Form 4, these amounts reflect the aggregate amount of shares controlled by Capital and Management (and by Scott Sacane through such entities) under Section 13(d) of the Exchange Act. Each Reporting Person disclaims beneficial ownership under Section 16 of the Exchange Act with respect to such transactions or securities, as applicable, to the extent greater than their indirect pecuniary interest therein.
3. Through Durus Life Sciences Master Fund Ltd.
Scott Sacane 07/30/2003
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.